|
33
|
154
|
5h9nA |
Crystal structure of ltbp1 y114a mutant in complex with leukotriene c4 |
|
39
|
139
|
5hbsA |
Crystal structure of human cellular retinol binding protein 1 in complex with all-trans-retinol at 0.89 angstrom. |
|
39
|
139
|
5h9aA |
Crystal structure of the apo form of human cellular retinol binding protein 1 |
|
33
|
132
|
5b27A |
The 1.02a structure of human fabp3 m20s mutant complexed with palmitic acid |
|
36
|
157
|
5hteA |
Recombinant bovine beta-lactoglobulin variant l1a/i2s (sblgb#2) |
|
39
|
148
|
5hceC |
Ternary complex of human complement c5 with ornithodoros moubata omci and rhipicephalus appendiculatus raci1 |
|
35
|
154
|
5h9lA |
Crystal structure of ltbp1 in complex with cleaved leukotriene c4 |
|
49
|
246
|
5b2aO |
Crystal structure of a mutant of ospa |
|
38
|
140
|
5ha1A |
Crystal structure of human cellular retinol binding protein 1 in complex with retinylamine |
|
49
|
246
|
5b3mO |
A mutant of ospa |
|
26
|
120
|
5b5gA |
Crystal structure of alis4-streptavidin complex |
|
39
|
154
|
5h9kA |
Crystal of a leukotriene-binding salivary lipocalin |
|
48
|
246
|
5b11O |
A mutation of ospa |
|
27
|
133
|
4zcbA |
Human crbpii mutant - y60w dimer |
|
47
|
246
|
5b10O |
A mutant of ospa |
|
32
|
146
|
5fq6E |
Crystal structure of the suscd complex bt2261-2264 from bacteroides thetaiotaomicron |
|
33
|
133
|
5f7gA |
Crystal structure of the q108k:k40l:t51v:r58y:y19w:q38l mutant of human cellular retinol binding protein ii in complex with all-trans-retinal at 1.48 angstrom resolution |
|
37
|
133
|
5fazA |
Crystal structure of the q108k:k40l:t51v mutant of human cellular retinol binding protein ii in complex with all-trans-retinal after 24 hours of incubation at 1.4 angstrom resolution |
|
43
|
166
|
5f6zA |
Sandercyanin fluorescent protein purified from sander vitreus |
|
36
|
145
|
5fq8E |
Crystal structure of the suscd complex bt2261-2264 from bacteroides thetaiotaomicron |
|
39
|
133
|
5f58A |
Crystal structure of the q108k:k40l:t51v:r58f mutant of human cellular retinol binding protein ii in complex with all-trans-retinal after 24 hours of incubation at 1.54 angstrom resolution |
|
36
|
133
|
5ffhA |
Crystal structure of the q108k:k40l:t51v:r58w:y19w mutant of human cellular retinol binding protein ii in complex with all-trans-retinal at 1.68 angstrom resolution |
|
35
|
133
|
5f6bA |
Crystal structure of the q108k:k40l:t51v:r58y:y19w mutant of human cellular retinol binding protein ii in complex with all-trans-retinal at 1.3 angstrom resolution |
|
32
|
145
|
5fq7E |
Crystal structure of the suscd complex bt2261-2264 from bacteroides thetaiotaomicron |
|
37
|
153
|
5epqA |
Structure at 1.75 a resolution of a glycosylated, lipid-binding, lipocalin-like protein |
|
34
|
133
|
5edcA |
Human fabp4 in complex with 6-chloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid at 1.29a |
|
37
|
167
|
5f1eA |
Apo protein of sandercyanin |
|
41
|
162
|
5eeeA |
Bovine lactoglobulin complex with decanol |
|
52
|
190
|
5aq6A |
Structure of e. coli zint at 1.79 angstrom |
|
44
|
169
|
5ez2A |
Sandercyanin fluorescent protein (sfp) |
|
31
|
134
|
5edbA |
Human fatty acid binding protein 4 in complex with 6-chloro-2-methyl-4-phenyl-quinoline-3-carboxylic acid at 1.18a |
|
26
|
122
|
5f2bA |
Expanding nature's catalytic repertoire -directed evolution of an artificial metalloenzyme for in vivo metathesis |
|
36
|
162
|
5eedA |
Ovine lactoglobulin complex with decanol |
|
28
|
133
|
4zr2A |
Crystal structure of the domain-swapped dimer k40l:q108k:y60w mutant of human cellular retinol binding protein ii |
|
28
|
133
|
5dpqA |
Crystal structure of e72a mutant of domain swapped dimer human cellular retinol binding protein |
|
35
|
133
|
5dg4A |
Crystal structure of monomer human cellular retinol binding protein ii-y60l |
|
34
|
136
|
5d4aA |
Crystal structure of fabp4 in complex with 3-(2-phenyl-1h-indol-1-yl)propanoic acid |
|
32
|
135
|
5d47A |
Crystal structure of fabp4 in complex with 3-[5-cyclopropyl-3-(3-methoxypyridin-4-yl)-2-phenyl-1h-indol-1-yl] propanoic acid |
|
28
|
133
|
5d8jA |
Development of a therapeutic monoclonal antibody targeting secreted ap2 to treat type 2 diabetes. |
|
27
|
121
|
5cseA |
Streptavidin-s112y-k121e complexed with palladium-containing biotin ligand |
|
13
|
89
|
5ajcA |
X-ray structure of rsl lectin in complex with sialyl lewis x tetrasaccharide |
|
37
|
137
|
4yfqA |
Crystal structure of the r111k:y134f:t54v:r132q:p39y:r59y mutant of human cellular retinoic acid binding proteinii with retinal after 24 hours incubation at 1.62 angstrom resolution - thermodynamic product - 1st cycle |
|
30
|
136
|
5d48A |
Crystal structure of fabp4 in complex with 3-{5-cyclopropyl-3-(3,5-dimethyl-1h-pyrazol-4-yl)-2-[3-(propan-2-yloxy) phenyl]-1h-indol-1-yl}propanoic acid |
|
36
|
137
|
4yggA |
Crystal structure of r111k:y134f:t54v:r132q:p39y:r59y mutant of human cellular retinoic acid binding protein ii with retinal at 1.9 angstrom resolution - visible light irradiated crystal - 2nd cycle |
|
18
|
89
|
5cybA |
Structure of a lipocalin lipoprotein affecting virulence in streptococcus pneumoniae |
|
36
|
137
|
4yfpA |
Crystal structure of the r111k:y134f:t54v:r132q:p39y:r59y mutant of human cellular retinoic acid binding protein ii with retinal after 20 minutes incubation at 1.95 angstrom resolution-kinetic product |
|
12
|
89
|
5ajbA |
X-ray structure of the rsl lectin in complex with lewis x tetrasaccahride |
|
34
|
137
|
4ygzA |
Crystal structure of the r111k:y134f:t54v:r132q:p39y:r59y mutant of human cellular retinoic acid binding protein ii with retinal at 2.06 angstrom resolution - visible light irradiated crystal -3rd cycle |
|
32
|
135
|
5d45A |
Crystal structure of fabp4 in complex with 3-(5-cyclopropyl-2,3-diphenyl-1h-indol-1-yl)propanoic acid |
|
35
|
137
|
4yh0A |
Crystal structure of the r111k:y134f:t54v:r132q:p39y:r59y mutant of human cellular retinoic acid binding protein ii in complex with retinal at 2.14 angstrom resolution - uv irradiated crystal - 3rd cycle |
